Redrawing the biopharma map: India’s rise in the biosimilars era
For India’s biopharma sector, 2025 stood out as an inflection point. The approval of 146 recombinant biosimilar therapeutic…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Cyrus Karkaria
The next frontier: Global leadership in biopharma
Cutting-edge research, future-ready talent, next-gen infrastructure, judicious investments and strategic collaborations are…
US FDA accepts biologics license application from Lupin for pegfilgrastim biosimilar
This BLA expands the company's oncology portfolio
‘Lupin has gained significant momentum towards development of biosimilar products with primary…
Lupin Biotech, with a new-age R&D facility in Pune, is developing and commercialising biosimilars globally. The successful…